Michael Tanen
Papers
1
Total Citations
20
H-Index
1
About
Dr. Michael Tanen is a clinical researcher whose work focuses on the early detection and prevention of acute kidney injury (AKI), particularly in the context of urological surgery. His most cited study, a 2018 feasibility investigation, explores the use of urinary renal biomarkers to predict AKI following partial nephrectomy—a critical step toward reducing postoperative renal complications. By evaluating novel molecular indicators, Dr. Tanen’s research aims to shift clinical practice from reactive treatment to proactive risk stratification, potentially sparing patients from irreversible kidney damage. With 20 citations, this work has already influenced discussions in nephrology and surgical outcomes research. Dr. Tanen’s contributions bridge the gap between biomarker science and real-world surgical care, offering a pathway to personalized, precision-based monitoring for at-risk patients. His ongoing efforts continue to refine these predictive models, underscoring his commitment to improving patient safety and long-term renal function in high-stakes surgical settings.
Research Focus
Key Achievements
Top Papers
- 1